(NUVL) Nuvalent - Performance 7.9% in 12m
Compare NUVL with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
56.50%
#9 in Group
Rel. Strength
56.37%
#3481 in Universe
Total Return 12m
7.90%
#48 in Group
Total Return 5y
306.56%
#7 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -3.71%
(?) Percentile in Group
12m Total Return: NUVL (7.9%) vs XBI (-5.4%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
-4.25% | 15.2% | 163% | 12.1 | 10.6 | 1.43 | 81.5% | 18.5% |
HLN NYSE Haleon |
2.64% | 25.8% | 43.6% | 24.4 | 20.2 | 1.79 | 64.4% | 6.58% |
AMGN NASDAQ Amgen |
-7.54% | 5.43% | 43.3% | 38.5 | 13.8 | 0.97 | -42.0% | -25.9% |
LONN SW Lonza |
8.68% | 15.4% | 38.7% | 65.8 | 33.6 | 1.23 | 12.6% | -10.3% |
BIM PA Biomerieux |
2.77% | 21.2% | 8.84% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
KMDA NASDAQ Kamada |
-1.94% | 25.9% | -9.16% | 26.6 | 24 | 0.96 | 80.4% | 43% |
ERF PA Eurofins Scientific SE |
15.4% | 0.42% | 17.2% | 26.6 | 13.6 | 0.56 | -67.4% | -17.7% |
BMRN NASDAQ Biomarin Pharmaceutical |
-7.7% | -24.7% | -30.6% | 28.6 | 15.9 | 0.43 | 67.5% | 59.7% |
Performance Comparison: NUVL vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for NUVL
Total Return (including Dividends) | NUVL | XBI | S&P 500 |
---|---|---|---|
1 Month | 12.10% | 5.55% | -0.45% |
3 Months | -10.16% | -9.75% | -6.29% |
12 Months | 7.90% | -5.39% | 13.04% |
5 Years | 306.56% | -13.20% | 111.82% |
Trend Score (consistency of price movement) | NUVL | XBI | S&P 500 |
1 Month | 85.6% | 70% | 47.5% |
3 Months | -67.2% | -88.1% | -87.3% |
12 Months | 2.50% | -44.4% | 54.3% |
5 Years | 88.3% | -53.6% | 84.2% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #85 | 6.21% | 12.6% |
3 Month | #75 | -0.45% | -4.13% |
12 Month | #48 | 14.1% | -4.55% |
5 Years | #3 | 516% | 204% |
FAQs
Does NUVL Nuvalent outperforms the market?
Yes,
over the last 12 months NUVL made 7.90%, while its related Sector, the SPDR S&P Biotech (XBI) made -5.39%.
Over the last 3 months NUVL made -10.16%, while XBI made -9.75%.
Over the last 3 months NUVL made -10.16%, while XBI made -9.75%.
Performance Comparison NUVL vs Indeces and Sectors
NUVL vs. Indices NUVL is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 0.89% | 12.6% | -13.0% | -5.14% |
US NASDAQ 100 | QQQ | -0.03% | 10.2% | -13.7% | -7.07% |
US Dow Jones Industrial 30 | DIA | 1.43% | 15.0% | -12.2% | -1.37% |
German DAX 40 | DAX | 1.25% | 12.3% | -31.1% | -17.1% |
Shanghai Shenzhen CSI 300 | CSI 300 | 4.54% | 15.3% | -9.28% | 2.93% |
Hongkong Hang Seng | HSI | 1.29% | 13.6% | -13.5% | -5.03% |
India NIFTY 50 | INDA | 3.41% | 7.22% | -12.9% | 5.0% |
Brasil Bovespa | EWZ | 2.52% | 9.27% | -18.7% | 14.6% |
NUVL vs. Sectors NUVL is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 0.74% | 12.7% | -19.0% | -15.6% |
Consumer Discretionary | XLY | 0.86% | 12.7% | -14.2% | -6.77% |
Consumer Staples | XLP | 2.95% | 12.9% | -17.1% | -3.04% |
Energy | XLE | 5.15% | 26.1% | -7.84% | 17.2% |
Financial | XLF | 2.0% | 14.1% | -19.9% | -14.8% |
Health Care | XLV | 3.59% | 16.8% | -7.82% | 9.13% |
Industrial | XLI | 0.57% | 11.8% | -14.0% | -2.79% |
Materials | XLB | 2.70% | 15.3% | -5.14% | 12.3% |
Real Estate | XLRE | 1.0% | 13.2% | -13.1% | -10.5% |
Technology | XLK | -0.67% | 9.67% | -10.0% | -2.54% |
Utilities | XLU | 2.17% | 12.0% | -17.4% | -12.9% |
Aerospace & Defense | XAR | -0.14% | 5.12% | -26.9% | -19.6% |
Biotech | XBI | 1.05% | 6.55% | 2.33% | 13.3% |
Homebuilder | XHB | 2.16% | 14.2% | 1.98% | 14.1% |
Retail | XRT | 2.13% | 13.3% | -7.02% | 9.41% |